OBJECTIVE: To determine the relation between plasma redox status and severity of illness for patients admitted to an intensive care unit (ICU). DESIGN: A prospective cohort study. SETTING: A mixed medical and surgical adult ICU with 12 beds. PATIENTS: A total of 73 consecutive patients admitted to the ICU. INTERVENTIONS: Venous blood samples were routinely obtained within 24 hrs of admission. MEASUREMENTS AND MAIN RESULTS: Plasma total antioxidant capacity and lipoperoxides were measured by spectrophotometric technique at admission to the ICU. The plasma ratio total antioxidant capacity (mM)/lipoperoxides (microM) was used as an index of plasma redox status. Plasma concentration of the markers of leukocyte activation myeloperoxidase (enzyme-linked immunosorbent assay) and polymorphonuclear-elastase (immunoactivation assay) were also measured at admission to the ICU. Analysis of correlation between plasma ratio total antioxidant capacity/lipoperoxides and APACHE III score showed a negative association (p < .001, Spearman correlation test). Myeloperoxidase and polymorphonuclear-elastase correlated positively with Acute Physiology and Chronic Health Evaluation III scores (r2 = 0.58; p < .001; and r2 = 0.05; p = .035; respectively). CONCLUSIONS: Plasma redox status relates to severity in critically ill patients. We propose that it would be reasonable to provide antioxidant therapy as part of routine management of patients admitted to a mixed ICU, regardless of the specific reason for ICU admission. Plasma redox status might become useful to evaluate the risk in critically ill patients.
OBJECTIVE: To determine the relation between plasma redox status and severity of illness for patients admitted to an intensive care unit (ICU). DESIGN: A prospective cohort study. SETTING: A mixed medical and surgical adult ICU with 12 beds. PATIENTS: A total of 73 consecutive patients admitted to the ICU. INTERVENTIONS: Venous blood samples were routinely obtained within 24 hrs of admission. MEASUREMENTS AND MAIN RESULTS: Plasma total antioxidant capacity and lipoperoxides were measured by spectrophotometric technique at admission to the ICU. The plasma ratio total antioxidant capacity (mM)/lipoperoxides (microM) was used as an index of plasma redox status. Plasma concentration of the markers of leukocyte activation myeloperoxidase (enzyme-linked immunosorbent assay) and polymorphonuclear-elastase (immunoactivation assay) were also measured at admission to the ICU. Analysis of correlation between plasma ratio total antioxidant capacity/lipoperoxides and APACHE III score showed a negative association (p < .001, Spearman correlation test). Myeloperoxidase and polymorphonuclear-elastase correlated positively with Acute Physiology and Chronic Health Evaluation III scores (r2 = 0.58; p < .001; and r2 = 0.05; p = .035; respectively). CONCLUSIONS: Plasma redox status relates to severity in critically illpatients. We propose that it would be reasonable to provide antioxidant therapy as part of routine management of patients admitted to a mixed ICU, regardless of the specific reason for ICU admission. Plasma redox status might become useful to evaluate the risk in critically illpatients.
Authors: Avery B Nathens; Margaret J Neff; Gregory J Jurkovich; Patricia Klotz; Katherine Farver; John T Ruzinski; Frank Radella; Iris Garcia; Ronald V Maier Journal: Ann Surg Date: 2002-12 Impact factor: 12.969
Authors: Stephen P Myers; Lesley Stevenson; Phillip A Cheras; Joan O'Connor; Lyndon Brooks; Margaret Rolfe; Paul Conellan; Carol Morris Journal: BMC Complement Altern Med Date: 2010-04-30 Impact factor: 3.659
Authors: E J Giamarellos-Bourboulis; D Plachouras; A Tzivra; V Kousoulas; N Bolanos; M Raftogiannis; I Galani; I Dontas; A Dionyssiou-Asteriou; H Giamarellou Journal: Clin Exp Immunol Date: 2004-02 Impact factor: 4.330
Authors: Menghua Luo; Concepcion Fernandez-Estivariz; Dean P Jones; Carolyn R Accardi; Birgit Alteheld; Niloofar Bazargan; Li Hao; Daniel P Griffith; Jeffrey B Blumberg; John R Galloway; Thomas R Ziegler Journal: Nutrition Date: 2008-01 Impact factor: 4.008
Authors: Mette M Berger; Philippe Eggimann; Daren K Heyland; René L Chioléro; Jean-Pierre Revelly; Andrew Day; Wassim Raffoul; Alan Shenkin Journal: Crit Care Date: 2006 Impact factor: 9.097
Authors: Leonard T Rael; Raphael Bar-Or; Kristin Salottolo; Charles W Mains; Denetta S Slone; Patrick J Offner; David Bar-Or Journal: Scand J Trauma Resusc Emerg Med Date: 2009-11-19 Impact factor: 2.953